[P26-2] P26-2: Central nervous system drugs (1)

[P26-2-3] Population pharmacokinetic modeling and simulation of topiramate using the routinely monitored data for the individualized dosage adjustment

Masato Takeuchi¹, Ikuko Yano², Satoko Ito³, Mitsuhiro Sugimoto⁴, Shota Yamamoto⁵, Atsushi Yonezawa⁶, Akio Ikeda⁷, Kazuo Matsubara⁸ (1.Kyoto University Hospital, 2.Kobe University Hospital, 3.Kyoto University Hospital, 4.Kyoto University Hospital, 5.Kyoto University Hospital, 6.Kyoto University Hospital, 7.Kyoto University Graduate School of Medicine, 8.Kyoto University Hospital)

Keywords:topiramate, epilepsy, population pharmacokinetics, modeling and simulation, CYP inducer